| 000 | 01073 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516235157.0 | ||
| 264 | 0 | _c20150127 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(14)70458-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Guo | |
| 245 | 0 | 0 |
_aDrug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cOct 2014 |
||
| 300 |
_ae469-70 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 700 | 1 | _aZheng, Qing-Shan | |
| 700 | 1 | _aWang, Da-Xin | |
| 700 | 1 | _aZhou, Hong-Hao | |
| 700 | 1 | _aLi, Guo-Fu | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 15 _gno. 11 _gp. e469-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(14)70458-9 _zAvailable from publisher's website |
| 999 |
_c24247100 _d24247100 |
||